NCT01590238View on ClinicalTrials.gov

Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

November 30, 2013

Conditions
Alopecia
Interventions
BIOLOGICAL

PRFM treatment

Study participants are treated in the initial visit, and at the 1 and 2 month follow-up visit. 4-8 cc of autologous platelet rich fibrin matrix (PRFM) is isolated from 9-18 cc of peripheral blood. PRFM is then injected intradermally in 0.10 cc aliquots in areas of alopecia for each treatment.

Trial Locations (1)

10003

The New York Eye & Ear Infirmary, New York

All Listed Sponsors
lead

The New York Eye & Ear Infirmary

OTHER

NCT01590238 - Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM) | Biotech Hunter | Biotech Hunter